Study number 8548-638
Dates
Jul 28 2025-Sep 23 2025
Location
Madison, Wisconsin
Age
18-55
Gender
Male and Female
Smoker
No
Compensation
$8,378
Group
A1a or A1b
The investigational drug in this research is being developed for the potential treatment of plycythemia vera, which, is a certain kind of cancer where the body produces too many red blood cells.
Women Eligibility Criteria
Body Mass Index (BMI)
Smoking Criteria
Medication Restrictions
Screening Procedures
A1a
Check-in: July 28
Check-out: July 31
Check-in: Aug 4
Check-out: Aug 5
Check-in: Sep 22
Check-out: Sep 23
Follow-up Visits: Aug 12, Sep 9
OR
A1b
Check-in: July 29
Check-out: Aug 1
Check-in: Aug 5
Check-out: Aug 6
Check-in: Sep 23
Check-out: Sep 24
Follow-up Visits: Aug 13, Sep 10